Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis

Pharmacogenomics and Personalized Medicine

Volumn 2, Issue 1, 2009, Pages 9-19

  Coller, Janet K ^a   Beardsley, Julia ^a   Bignold, James ^a   Li, Yibai ^a   Merg, Florence ^a   Sullivan, Thomas ^a   Cox, Timothy C ^a,b,c   Somogyi, Andrew A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

A118G genotype; Meta analysis; Mu opioid receptor; Opioid dependence

Indexed keywords

MU OPIATE RECEPTOR AGONIST; OPIATE;

ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE; HEROIN DEPENDENCE; HUMAN; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 72849115311     PISSN: None     EISSN: 11787066     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Drakenberg N, Nikoshkov A, Horvath MC, et al. Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers. Proc Natl Acad Sci U S A. 2006;103:7883-7888.
2. Bond C, LaForge KS, Tian M, et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters b-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A. 1998;95:9608-9613.
3. Ikeda K, Ide S, Han W, et al. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci. 2005;26:311-317.
4. Kreek MJ, LaForge KS. Stress responsivity, addiction, and a functional variant of the human mu-opioid receptor gene. Mol Intervent. 2007;7:74-78.
5. Arias A, Feinn R, Kranzler HR. Association of an Asn40Asp (A118G) polymorphism in the m-opioid receptor gene with substance dependence: A meta-analysis. Drug Alcohol Depend. 2006;83:262-268.
6. Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA. Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005;57:1-26.
7. Tsuang MT, Lyons MJ, Meyer JM, et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 1998;55:967-972.
8. Bart G, Heilig M, LaForge KS, et al. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry. 2004;9:547-549.
9. Glatt SJ, Bousman C, Wang RS, et al. Evaluation of OPRM1 variants in heroin dependence by family-based association testing and metaanalysis. Drug Alcohol Depend. 2007;90:159-165.
10. Landau R, Kern C, Columb MO, Smiley RM, Blouin J-L. Genetic variability of the mu-opioid receptor infl uences intrathecal fentanyl analgesia requirements in laboring women. Pain. 2008;139:5-14.
11. Crowley JJ, Oslin DW, Patkar AA, et al. A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet. 2003;13:169-173.
12. Franke P, Wang T, Nothen MM, et al. Nonreplication of association between m-opioid receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet. 2001;105:114-119.
13. Kapur S, Sharad S, Singh RA, Gupta AK. A118G polymorphism in mu opioid receptor gene (OPRM1): association with opiate addiction in subjects of Indian origin. J Integr Neurosci. 2007;6:511-522.
14. Crettol S, Besson J, Croquette-Krokar M, et al. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment. Prog Neuro-Psychopharmacol Biol Psych. 2008;32:1722-1727.
15. Jorm AF, Prior M, Sanson A, et al. Lack of association of a singlenucleotide polymorphism of the m-opioid receptor gene with anxietyrelated traits: results from a cross-sectional study of adults and a longitudinal study of children. Am J Med Genet. 2002;114:659-664.
16. Gelernter J, Kranzler H, Cubells J. Genetics of two mu opioid receptor gene (OPRM1) exon 1 polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry. 1999;4:476-483.
17. Hoehe MR, Kopke K, Wendel B, et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet. 2000;9:2895-2908.
18. Li T, Liu X, Zhu ZH, et al. Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects. Addict Biol. 2000;5:181-186.
19. Luo X, Kranzlet HR, Zhao H, Gelernter J. Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet. 2003;120B:97-108.
20. Shi J, Hui L, Xu Y, et al. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat. 2002;19:459-460.
21. Szeto CY, Tang NL, Lee DT, Stadlin A. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport. 2001;12:1103-1106.
22. Tan EC, Tan CH, Karupathivan U, Yap EP. Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport. 2003;14:569-572.
23. Zhang H, Luo X, Kranzler HR, et al. Association between two m-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet. 2006;15:807-819.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R). 3rd revised ed. Washington, DC: American Psychiatric Association; 1987.
25. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association; 1994.
26. Coffman BL, Kearney WR, Goldsmity S, Knosp BM, Tephly TR. Opioids bind to the amino acids 84 and 118 of UDP-glucuronosyltransferase UGT2B7. Mol Pharmacol. 2003;63:283-288.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
28. Livingston M, Messura J, Dellinger T, Holder R, Hyde J. Metaanalysis: an introduction into a research process. Spec Care Dentist. 2008;28:125-130.
29. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002;21:1539-1558.
30. Sharp S. sbe23: Meta-analysis regression. Stata Tech Bull. 1998;42: 16-24.
31. Egger M, Davey Smith G, Schnider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
32. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
33. Pud D, Yarnitsky D, Sprecher E, et al. Can personality traits and gender predict the response to morphine? An experimental cold pain study. Eur J Pain. 2006;10:103-112.
34. Ray R, Jepson C, Patterson F, et al. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology. 2006;188:355-363.
35. Somogyi A A, Barratt DT, Coller JK. Pharmacogenetics of opioids. Clin Pharmacol Ther. 2007;81:429-444.